Jazz Pharmaceuticals JAZZ Other current assets
Other current assets at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's other current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Jazz Pharmaceuticals's other current assets?
- Jazz Pharmaceuticals (JAZZ) reported other current assets of $285.3M in Q1 2026.
- How has Jazz Pharmaceuticals's other current assets changed year-over-year?
- Jazz Pharmaceuticals's other current assets increased by 9.8% year-over-year, from $259.82M to $285.3M.
- What is the long-term trend for Jazz Pharmaceuticals's other current assets?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's other current assets has grown at a 16.3% compound annual growth rate (CAGR), from $152.49M to $323.9M.